[Federal Register Volume 88, Number 245 (Friday, December 22, 2023)]
[Notices]
[Pages 88620-88621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28174]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-1074; Docket No. CDC-2023-0100]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Colorectal Cancer Control Program (CRCCP) Monitoring Activities. 
CDC is requesting an Extension to OMB Control No. 0920-1074 to continue 
information collection via an annual survey, a clinic-level data 
collection instrument, and a quarterly recipient-level program update 
survey.

DATES: CDC must receive written comments on or before February 20, 
2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0100 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Colorectal Cancer Control Program (CRCCP) Monitoring Activities 
(OMB Control No. 0920-1074, Exp. 03/31/2024)--Extension--National 
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Colorectal cancer (CRC) is the second leading cause of death from 
cancer in the United States among cancers that affect both men and 
women. There is substantial evidence that CRC screening reduces the 
incidence of, and death from the disease. Screening for CRC can detect 
disease early when treatment is more effective, and can prevent cancer 
by finding and removing precancerous

[[Page 88621]]

polyps. Of individuals diagnosed with early stage CRC, more than 90% 
live five or more years. Despite strong evidence supporting screening, 
only 68.8% of adults currently report being up-to-date with CRC 
screening as recommended by the U.S. Preventive Services Task Force in 
2018, with more than 22 million age-eligible adults estimated to be 
untested. To reduce CRC morbidity, mortality, and associated costs, use 
of CRC screening tests must be increased among age-eligible adults with 
the lowest CRC screening rates.
    The purpose of the Colorectal Cancer Control Program (CRCCP) is to 
partner with health systems and their individual primary care clinics 
to implement Evidence-based interventions (EBIs) to increase CRC 
screening among defined populations of adults ages 50-75 that have CRC 
screening rates lower than the national, regional, or local rate. In 
2020, CDC issued the funding opportunity, Public Health and Health 
System Partnerships to Increase Colorectal Cancer Screening in Clinical 
Settings (DP20-2002), a 5-year cooperative agreement to increase CRC 
screening among defined populations of adults ages 50-75 that have CRC 
screening rates lower than the national, regional, or local rate. DP20-
2002 funds recipients to partner with health systems and their primary 
care clinics to implement multiple EBIs, partner with organizations to 
support implementation of EBIs in those clinics, and collect high-
quality clinic-level data when a clinic is recruited to participate 
(baseline) and annually thereafter to monitor EBI implementation and 
assess screening rate changes. DP20-2002 also requires recipients to 
conduct a formal capacity/readiness assessment of potential clinics to 
implement EBIs, use assessment findings to select appropriate EBIs for 
implementation, and provide clinics with limited financial resources to 
support follow-up colonoscopies for under- and uninsured patients after 
an abnormal CRC screening test.
    CDC proposes three information collections--the Annual Awardee 
Survey, the Clinic-Level Data Collection Instrument, and the Quarterly 
Program Update--to reflect the strategies and objectives detailed in 
DP20-2002. CDC will conduct data collections for each of these three 
proposed activities among all 35 recipients following the end of each 
program year which runs from July 1-June 30.
    The Annual Awardee Survey assesses: (1) program management; (2) 
clinic readiness assessment activities; (3) data management; (4) 
technical assistance (TA) needs; (5) partnerships; and (6) the effect 
of COVID-19 on CRC implementation at the recipient level.
    The Clinic-level Information Collection Instrument assesses: (1) 
health system and clinic characteristics; (2) program reach; (3) CRC 
screening practices and outcomes; (4) clinics' quality improvement and 
monitoring activities; (5) EBI implementation; and (6) additional 
factors that affect EBI implementation over time.
    The Quarterly Program Update will collect standardized recipient-
level information on aspects of program management, including: (1) 
quarterly program expenditures; (2) current staff vacancies; (3) 
program successes and challenges; (4) current TA needs; and (5) the 
effect of COVID-19 on CRCCP implementation at the recipient level. 
These data are collected quarterly to enable rapid reporting of 
programmatic information to support CDC program consultants in 
providing tailored and meaningful TA.
    This information collection enables CDC to gauge progress in 
meeting CRCCP program goals and monitor implementation activities, 
evaluate outcomes, and identify recipients' TA needs. In addition, data 
collected will inform program improvement and help identify successful 
activities that need to be maintained, replicated, or expanded. CDC is 
requesting a 3-year Extension to the Colorectal Cancer Control Program 
(CRCCP) Monitoring Activities collection (OMB No. 0920-1074). The total 
estimated annualized burden is 760 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                            Average
                                                              Number of      Number of     burden per    Total
        Type of respondent                 Form name         respondents   responses per    response     burden
                                                                            respondent      (in hr)     (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Recipients.................  CRCCP Annual Awardee               35               1        15/60          9
                                    Survey.
                                   CRCCP Clinic-level                 35              24        50/60        700
                                    Information Collection
                                    Instrument.
                                   CRCCP Quarterly Program            35               4        22/60         51
                                    Update.
                                                            ----------------------------------------------------
    Total........................  ........................  ...........  ..............  ...........        760
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-28174 Filed 12-21-23; 8:45 am]
BILLING CODE 4163-18-P